dostarlimab rectal cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
dostarlimab rectal cancer	1.37	0.3	7760	91	25
dostarlimab	1.75	0.5	354	99	11
rectal	0.1	0.2	4690	39	6
cancer	1.86	0.9	9211	14	6

Keyword	CPC	PCC	Volume	Score
dostarlimab rectal cancer	1.28	0.1	1668	16
dostarlimab rectal cancer trial	0.6	0.7	8089	55
dostarlimab rectal cancer nejm	0.04	0.5	4789	33
dostarlimab rectal cancer fda	1.92	0.7	232	75
dostarlimab rectal cancer asco	0.98	0.2	5515	6
dostarlimab rectal cancer study	0.45	0.2	4756	88
rectal cancer drug trial dostarlimab	1.21	0.6	4741	72
dostarlimab and rectal cancer	1.3	0.6	8054	100
dostarlimab for rectal cancer	0.58	1	3139	2
dostarlimab trial colorectal cancer	1.13	0.5	1195	70
dostarlimab colon cancer trial	0.66	0.5	4447	38
dostarlimab clinical trials colon cancer	0.83	0.9	6960	3
dostarlimab for colorectal cancer	1.41	0.4	1645	69
rectal cancer drug trial	0.46	0.9	8459	17
dostarlimab for colon cancer	1.39	0.7	3379	93
dostarlimab fda approval colon cancer	0.25	1	6434	34
rectal cancer treatment trial	0.24	0.5	6828	33
dostarlimab and prostate cancer	0.26	0.9	2592	58
swedish rectal cancer trial	1.28	0.3	7276	70
german rectal cancer trial	0.5	1	1983	52
dostarlimab chemotherapy endometrial cancer	0.22	0.6	9605	29
dostarlimab for endometrial cancer	1.84	0.4	5986	46
dostarlimab endometrial cancer fda	1.58	0.6	9185	98
dostarlimab for pancreatic cancer	0.9	0.9	887	9